Dr Gavin Clunie MD FRCP
Rheumatologist & Metabolic Bone physician
Medical qualifications: [Dr Gavin Clunie]
MBBS, BSc, MD, FRCP
Addenbrooke's Hospital Cambridge (NHS Practice)
Areas of expertise:
• arthritis (all types: eg rheumatoid arthritis, spondylarthropathies, osteoarthritis)
• autoimmune connective tissue diseases (eg lupus, sjögrens, scleroderma)
• osteoporosis and other bone diseases
• hypermobility disorders
• back pain disorders
• psoriasis-related musculoskeletal disease (eg enthesitis, tendonitis, dactylitis, backpain).
• soft-tissue and regional pain conditions (eg shoulder pain, tendonitis, carpal tunnel, elbow pains, plantar fasciitis [heel pain])
• Fellow of The Royal College of Physicians
• American Society for Bone and Mineral Research
• National Osteoporosis Society
• British Society for Rheumatology
• Bone Research Society
• Fellow of The Royal Geographical Society
Dr Clunie is a senior UK Rheumatologist and Metabolic Bone Physician (NHS work at Addenbrookes). He was an NHS Consultant Rheumatologist in Ipswich for 12 years (2000-12) and has had a substantial subspecialty interest in metabolic bone diseases (osteoporosis included) for much longer.
Dr Clunie trained at UCL completing a BSc in Human Genetics, then after graduating in medicine, a postgraduate Medical Doctorate in the use of radiopharmaceuticals and imaging their effect as applied to musculoskeletal disease. He completed his Rheumatology specialist training in London and was appointed Consultant Rheumatologist in Ipswich in 2000. He had by then developed an interest in metabolic bone diseases having trained for a year at The Royal National Orthopedic Hospital and run the UCLH DXA unit for 3 years.
In Ipswich Dr Clunie set up and ran a Metabolic Bone Unit creating England’s first Fracture Liaison Service. Since that time the Service has become a beacon service, used as a template for similar services implemented in The UK and worldwide and cited extensively.
Dr Clunie’s Metabolic Bone Disease interest includes the development of clinical services for rare diseases, having set up the forum for bringing together research scientists and clinicians regularly under the auspices of The Bone Research Society over the last five years. Dr Clunie moved to Cambridge in 2012 to lead the Clinical Metabolic Bone Service and develop Services for patients with Spondyloarthritis.
Dr Clunie has pioneered the development of Fracture Liaison Services in the UK working with The Department of Health, National Osteoporosis Society, National Hip Fracture Database and other agencies over the last 5 years. He has been Clinical Lead/Director of DXA (‘DEXA’) scanning units in both Ipswich and London (UCL) previously but now runs the DXA Unit at Addenbrooke’s and reports DXA scans for The Cambridge Spire Lea Hospital. He leads on NHS Services for patients with rare bone diseases (e.g.osteogenesis Imperfecta, fibrous dysplasia, skeletal dysplasias, XLH etc) in East Anglia and advises NHS England on development of national service configuration.
Dr Clunie has published research in both bone and rheumatological diseases and is the author-editor of 3 standard textbooks: 2 in rheumatology (Oxford Handbook and Desk-Reference) and one on osteoporosis. Dr Clunie was awarded the title of Midlands and East Anglia Hospital Doctor of the Year 2004 in the Health and Social Care Awards - in recognition of his battle to provide first-class medical care for people with the bone disease osteoporosis. Dr Clunie’s father and brother are both GPs, and he is passionate about the unique value of the NHS.
Dr Clunie represents BSR at The Fracture Liaison Service Database Advisory Group convened by The Royal College of Physicians within the falls and fragility fracture audit programme – (link.) and is clinical advisor to ARMA (arma.uk.net).